Nuclear medicine is a branch of medical imaging and treatment that uses small amounts of radioactive materials to diagnose and treat disease. Unlike an X-ray or CT scan, which shows the structure of your body, nuclear medicine reveals how your organs and tissues are actually functioning at the molecular level. This makes it uniquely powerful for catching diseases early, staging cancers, and even delivering targeted radiation therapy directly to tumors.
How Radioactive Tracers Work
The core tool of nuclear medicine is a radiopharmaceutical, commonly called a tracer. A tracer is a small amount of radioactive material attached to a molecule your body naturally interacts with, like sugar, a hormone, or an antibody. Once injected, swallowed, or inhaled, the tracer travels through your body and accumulates in the specific organ or tissue being studied. A special camera then detects the radiation the tracer emits, creating images that show how that area is working.
What makes this different from a standard X-ray is the direction of information. An X-ray beams radiation through you from the outside. In nuclear medicine, the radiation comes from inside your body, emitted by the tracer itself. This means the images reflect biological activity, not just anatomy. A bone scan, for example, highlights areas of rapid bone repair that could signal a fracture, infection, or cancer spread, even when the bone still looks normal on an X-ray.
Tracers are designed with specific targets. Some bind to receptors on the surface of cancer cells. Others get absorbed by organs that naturally take up certain substances, like the thyroid gland with iodine. The radioactive component decays quickly. Technetium-99m, the most widely used tracer in nuclear medicine, has a half-life of just 6 hours, meaning half its radioactivity is gone within that time. For PET scans, fluorine-18 decays even faster, with a half-life under 2 hours.
The Two Main Imaging Technologies
Nuclear medicine imaging falls into two main categories: SPECT and PET. Both produce three-dimensional images of what’s happening inside your body, but they work differently and serve different purposes.
SPECT Scans
Single photon emission computed tomography (SPECT) uses tracers that emit gamma rays detected by a rotating camera. The workhorse tracer is technetium-99m, valued for its versatile chemistry and ideal energy level for imaging. SPECT is the technology behind bone scans, cardiac stress tests, and certain brain imaging studies. It’s widely available and less expensive than PET, making it the more common choice for routine nuclear medicine exams.
PET Scans
Positron emission tomography (PET) offers sharper images and greater sensitivity. PET tracers emit positrons that interact with nearby electrons, producing paired signals the scanner detects simultaneously. This gives PET better spatial resolution and more accurate measurements of tracer concentration, especially in small lesions. PET is indispensable for cancer staging, monitoring treatment response, and evaluating brain conditions like Alzheimer’s disease. It’s often combined with a CT scan (PET/CT) to overlay functional and structural images in a single session.
The practical difference for patients: PET is better at detecting small or subtle abnormalities, while SPECT handles many common diagnostic questions reliably and at lower cost.
Common Diagnostic Uses
Nuclear medicine touches nearly every organ system. Some of the most frequent reasons you might have a nuclear medicine scan include:
- Heart disease: Cardiac stress tests use a tracer to show blood flow to heart muscle at rest and during exercise, revealing blocked arteries that might not show up otherwise.
- Cancer: PET scans detect metabolically active tumors throughout the body, help determine whether cancer has spread, and track how well chemotherapy is working.
- Bone injuries and disease: Bone scans pick up stress fractures, infections, and metastatic cancer in the skeleton, often weeks before changes appear on standard imaging.
- Thyroid disorders: Iodine-based tracers evaluate thyroid function and detect overactive nodules or cancer.
- Kidney function: Renal scans measure how well each kidney filters and drains, which is especially useful before surgery.
- Brain conditions: Specialized tracers help distinguish types of dementia, locate seizure sources in epilepsy, and assess brain blood flow.
Nuclear Medicine as Treatment
Nuclear medicine isn’t just for diagnosis. The same principle of targeted delivery can be used therapeutically, sending radiation directly to diseased cells while largely sparing healthy tissue. This is fundamentally different from external beam radiation, where a machine aims radiation at you from outside.
The oldest and most established example is radioactive iodine for thyroid disease. Because the thyroid naturally absorbs iodine, swallowing a capsule of iodine-131 delivers radiation straight to thyroid cells. This treats both overactive thyroid (Graves’ disease) and thyroid cancer, often as a single outpatient dose. Iodine-131 has a half-life of about 8 days, so the radiation clears your body over a few weeks.
For bone pain caused by cancer that has spread to the skeleton, injectable radiopharmaceuticals seek out areas of active bone turnover and deliver localized radiation to relieve pain.
The “See and Treat” Approach
One of the most exciting areas in nuclear medicine is theranostics, a combination of “therapy” and “diagnostics.” The idea is straightforward: use one version of a tracer to image the disease, then swap in a therapeutic version of the same tracer to treat it. If the diagnostic scan shows the tracer accumulating in the tumor, there’s strong reason to believe the therapeutic version will reach the same target.
This approach has been transformative for advanced prostate cancer. A tracer that binds to a protein called PSMA on prostate cancer cells is first used for imaging. If the scan confirms PSMA-positive disease, the same molecule is paired with a therapeutic radioisotope (lutetium-177) and administered as treatment. In a phase II trial of 30 patients with advanced prostate cancer who had failed standard therapies, 57% saw their PSA levels drop by more than half. Among those with measurable tumors, 71% had an objective reduction in tumor size. Over a third reported meaningful improvement in quality of life after just one cycle, and 43% of those with bone pain experienced significant relief.
Similar theranostic strategies now target neuroendocrine tumors using tracers that bind to somatostatin receptors on tumor cells. The field is expanding rapidly as researchers identify new molecular targets across cancer types.
What to Expect During a Scan
A nuclear medicine scan is painless, though it requires patience. The general sequence involves receiving the tracer, waiting for it to reach the target area, and then lying still while the camera captures images.
The waiting period varies considerably depending on the exam. For a cardiac stress test, you’ll wait about 45 to 60 minutes after the tracer injection before imaging begins. A bone scan requires a 3-hour gap between injection and the main scan. A kidney scan using certain tracers means returning 4 hours later. Some specialized studies, like white blood cell scans for hidden infections, can span 18 to 24 hours from start to finish.
Preparation requirements also differ by exam. Many scans require you to fast for 6 hours beforehand, including cardiac stress tests, gallbladder scans, and gastric emptying studies. Kidney scans call for drinking plenty of water. For brain imaging, you’ll rest quietly for about 20 minutes before the tracer is injected to establish a baseline brain state. Your ordering physician or the nuclear medicine department will give you specific instructions.
The imaging itself is straightforward. You’ll lie on a table while a camera either rotates around you or is positioned close to your body. Bone scans take about 30 to 60 minutes of imaging time. Cardiac scans involve two rounds of imaging, one at rest and one after exercise or a medication that simulates exercise.
Radiation Exposure in Perspective
The average effective radiation dose from most nuclear medicine procedures falls between 0.3 and 20 millisieverts (mSv). For context, the natural background radiation you absorb every year from the environment is roughly 3 mSv. A bone scan delivers about 6 mSv, comparable to a couple of years of background radiation. A PET/CT scan for cancer staging sits at the higher end, around 15 to 25 mSv when the CT component is included.
The tracers themselves clear your body quickly through natural decay and urination. Drinking extra water after most scans helps flush the tracer faster. For the vast majority of patients, the diagnostic benefit of the scan far outweighs the small radiation exposure.
Pregnancy and Breastfeeding
Radioactive tracers can cross the placenta, so nuclear medicine scans are generally avoided during pregnancy unless the clinical need is urgent and no alternative exists.
For breastfeeding, the picture is more nuanced. Some tracers require no interruption of breastfeeding at all. Others call for pumping and discarding breast milk for 3 to 48 hours, depending on the specific isotope used. The one absolute exception is iodine-131: because iodine concentrates in breast tissue and passes directly into breast milk, permanent discontinuation of breastfeeding is required after treatment. For all other radiopharmaceuticals, the recommended withdrawal period is typically a minimum of 5 half-lives of the isotope, sometimes up to 10. With technetium-99m’s 6-hour half-life, that means a relatively short interruption. Your nuclear medicine team will give you a specific timeline based on the tracer you receive.